Evolutionarily, a human organism is adapted to the natural geomagnetic environment and its slight alterations. However, during geomagnetic storms (GMSs), the strength of the geomagnetic field (GMF) sharply increased hundreds of times and can pose a serious threat to people. We examine the effects of controlled compensation in the time-varying components of the GMF, using a specially created experimental setup with electrically shielding solutions, providing an electromagnetically quiet environment.
View Article and Find Full Text PDFArterial hypertension is the most common risk factor in patients with metabolic disorders. In the selection of antihypertensive therapy it is necessary to consider not only the anti-hypertensive and organoprotective effects of drugs and their metabolic effects, which has prognostic value. Calcium antaginists, along.
View Article and Find Full Text PDFPatients' therapeutic education is one of the modern approaches to improvement of quality of chronic heart failure (CHF) treatment. Purpose of the study was evaluation of the effect of therapeutic education on life quality and need of rehospitalization in patients with CHF. 57 patients with CHF of NYHA III-IV functional class (FC) randomized in two - intervention and control groups - were observed.
View Article and Find Full Text PDFUnlabelled: To assess effects of enalapril and Accupro on clinical status left ventricular remodeling and systolic function in patients with heart failure due to dilated cardiomyopathy.
Study Structure: Randomized, open, controlled, duration -- 6 months.
Patients: 31 patients with dilated cardiomyopathy (mean age 46+/-2 years).
The efficacy of angiotensin converting-enzyme inhibitors in the therapy of chronic heart failure are well documented and is mainly explained by a decrease of afterload via reduction of angiotensin II formation in the vascular system and myocardium. The aim of our study was to study the effectiveness of ACCUPRO on structural and hemodynamic indices in patients with heart failure. 37 patients aged 61-84 years with postinfarction cardiosclerosis and mild or moderate hypertension, class I-III heart failure received Accupro (13,7+/-0,97 mg/day) for 3 months in combination with furosemide (40-80 mg 1-3 times a week).
View Article and Find Full Text PDF